Recall: Zelnorm

Jul. 2022Pharmacy Updates

Alfasigma USA Inc. will no longer make Zelnorm® available in the U.S. marketplace effective June 30, 2022. This medication is used to treat irritable bowel syndrome with constipation (IBS-C) in adult women younger than 65 years old. Read the full text of the Zelnorm recall.

Recent Announcements

Special notice: Important policy changes

Effective June 1, 2025, UPMC Health Plan will be implementing policy changes that will require providers to obtain prior authorizations for services listed in the following policies. For more information, please visit upmchp.us/policiesandprocedures.

May 2025Important Notices

Provider OnLine Enhancements

Provider OnLine will be launching enhancements to the authorization process on April 18, 2025. The enhancement will include the following updates:

Apr. 2025Important Notices

Fostering Trust in Vaccinations Through Shared Decision Making

Please join us for a live, CME-accredited webinar on Wednesday, June 4, from noon to 1 p.m. that will provide an overview of fostering trust in vaccinations through shared decision making.

Apr. 2025Education/Webinars